FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213286871> ?p ?o ?g. }

• W4213286871 abstract "Abstract Background : In the era of “test and treat strategy”, CD4 testing remains an important tool for monitoring HIV-infected individuals. Since conventional methods of CD4 count measurement are costly and cumbersome, POC CD4 counting technique are more affordable and practical for countries with limited resources. Before introducing such methods in Morocco, we decided to assess their reliability. Methods : In this study 92 blood samples from HIV-infected patients, were tested by PIMA and FACSPresto to derive CD4 count. Flow cytometry using FacsCalibur, was used as reference method for CD4 count comparison. Linear regression, Bland-Altman analysis were performed to assess correlation and agreement between these POC methods and the reference method. In addition, sensitivity and specificity, positive predictive value (PPV), negative predictive value (NPV) and misclassification percentage at 350 and 200 CD4 count thresholds; were also determined. Finally, because FACSPresto can also measure hemoglobin (Hb) concentration, 52 samples were used to compare FACSPresto against an automated hematology analyzer. Results : The coefficient of determination R 2 was 0.93 for both methods. Bland-Altman analysis displayed a mean bias of -32.3 and -8.1 cells/µl for PIMA and FACSPresto, respectively. Moreover, with a threshold of 350 CD4 count, PIMA displayed a sensitivity, specificity, PPV, NPV, were 88.57%, 94.12%, 91.18%, 92.31%; respectively. FACSPresto showed 88.23%, 96.23%,93.75% and 92.73%; respectively. Furthermore, the upward misclassification percentage was 8.57 and 5.88%, for PIMA and FACSPresto, respectively; whereas the downward misclassification percentage was 7.84% and 7.54%; respectively. With 200 cells/µl threshold, PIMA had a sensitivity, specificity, PPV and NPV of 83.33%, 98.53%, 93.75% and 95.71%, respectively. Regarding FACSPresto, sensitivity, specificity, PPV and NPV was 82.35%, 98.57%, 88.57% and 95.83%; respectively. Upward misclassification percentage was 5.56% and 5.88%, for PIMA and FACSPresto, respectively; whereas downward misclassification percentage was 4.41% and 4.29%; respectively. Finally, the hemoglobin measurement evaluation displayed an R 2 of 0.80 and a mean bias of-0.12 with a LOA between -1.75 and 1.51. Conclusion : When compared to the reference method, PIMA and FACSPresto have shown good performance, for CD4 counting. The introduction of such POC technology will speed up the uptake of patients in the continuum of HIV care, in our country." @default.
• W4213286871 created "2022-02-24" @default.
• W4213286871 creator A5057304218 @default.
• W4213286871 creator A5059460878 @default.
• W4213286871 creator A5059807572 @default.
• W4213286871 creator A5066385380 @default.
• W4213286871 creator A5071538428 @default.
• W4213286871 creator A5075931212 @default.
• W4213286871 date "2020-06-05" @default.
• W4213286871 modified "2023-09-28" @default.
• W4213286871 title "Assessment of two POC technologies for CD4 count in Morocco" @default.
• W4213286871 doi "https://doi.org/10.21203/rs.2.21519/v3" @default.
• W4213286871 hasPublicationYear "2020" @default.
• W4213286871 type Work @default.
• W4213286871 citedByCount "0" @default.
• W4213286871 crossrefType "posted-content" @default.
• W4213286871 hasAuthorship W4213286871A5057304218 @default.
• W4213286871 hasAuthorship W4213286871A5059460878 @default.
• W4213286871 hasAuthorship W4213286871A5059807572 @default.
• W4213286871 hasAuthorship W4213286871A5066385380 @default.
• W4213286871 hasAuthorship W4213286871A5071538428 @default.
• W4213286871 hasAuthorship W4213286871A5075931212 @default.
• W4213286871 hasBestOaLocation W42132868711 @default.
• W4213286871 hasConcept C105795698 @default.
• W4213286871 hasConcept C126322002 @default.
• W4213286871 hasConcept C142462285 @default.
• W4213286871 hasConcept C203014093 @default.
• W4213286871 hasConcept C2989005 @default.
• W4213286871 hasConcept C2993143319 @default.
• W4213286871 hasConcept C2993758460 @default.
• W4213286871 hasConcept C3013748606 @default.
• W4213286871 hasConcept C3018577593 @default.
• W4213286871 hasConcept C3019719930 @default.
• W4213286871 hasConcept C33923547 @default.
• W4213286871 hasConcept C48921125 @default.
• W4213286871 hasConcept C71924100 @default.
• W4213286871 hasConceptScore W4213286871C105795698 @default.
• W4213286871 hasConceptScore W4213286871C126322002 @default.
• W4213286871 hasConceptScore W4213286871C142462285 @default.
• W4213286871 hasConceptScore W4213286871C203014093 @default.
• W4213286871 hasConceptScore W4213286871C2989005 @default.
• W4213286871 hasConceptScore W4213286871C2993143319 @default.
• W4213286871 hasConceptScore W4213286871C2993758460 @default.
• W4213286871 hasConceptScore W4213286871C3013748606 @default.
• W4213286871 hasConceptScore W4213286871C3018577593 @default.
• W4213286871 hasConceptScore W4213286871C3019719930 @default.
• W4213286871 hasConceptScore W4213286871C33923547 @default.
• W4213286871 hasConceptScore W4213286871C48921125 @default.
• W4213286871 hasConceptScore W4213286871C71924100 @default.
• W4213286871 hasLocation W42132868711 @default.
• W4213286871 hasLocation W42132868712 @default.
• W4213286871 hasOpenAccess W4213286871 @default.
• W4213286871 hasPrimaryLocation W42132868711 @default.
• W4213286871 hasRelatedWork W10478721 @default.
• W4213286871 hasRelatedWork W11226827 @default.
• W4213286871 hasRelatedWork W11571637 @default.
• W4213286871 hasRelatedWork W18243548 @default.
• W4213286871 hasRelatedWork W20066259 @default.
• W4213286871 hasRelatedWork W2238006 @default.
• W4213286871 hasRelatedWork W4424148 @default.
• W4213286871 hasRelatedWork W9607311 @default.
• W4213286871 hasRelatedWork W9892787 @default.
• W4213286871 hasRelatedWork W14353572 @default.
• W4213286871 isParatext "false" @default.
• W4213286871 isRetracted "false" @default.
• W4213286871 workType "article" @default.